Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).
Maki IshiiIkuko HiraiKeiji TaneseTakayuki FusumaeYoshio NakamuraKeitaro FukudaHiroshi UchiKenji KabashimaAtsushi OtsukaKenji YokotaNaoya YamazakiKenjiro NamikawaTaku FujimuraTatsuya TakenouchiYuki YamamotoMana NishiguchiYasunori SatoMasayuki AmagaiTakeru FunakoshiPublished in: Medicine (2020)
Registry number: jRCT 2031190048.